Articles related to Infectious Diseases

The American Academy of Pediatrics expanded its definition of children at high risk for severe RSV disease who should receive immunization before their second RSV season, adding several congenital, developmental, and prematurity-related conditions to existing eligibility criteria.

A perspective article argues that vaccine-hesitant parents often communicate uncertainty indirectly through delays, scheduling questions, or silence rather than explicit refusal. The author proposes an “announce, detect, switch” framework that warrants prospective evaluation before broader adoption.

A multisociety consensus paper outlines hospital-level strategies to improve sepsis outcomes, emphasizing diagnostic stewardship, antimicrobial optimization, surveillance, infection prevention, and multidisciplinary infrastructure while prioritizing interventions judged most feasible and impactful for broad implementation.

A multicenter cross-sectional study associated symptomatic uncomplicated diverticular disease with reduced microbial diversity and distinct taxonomic and predicted functional patterns. The findings remain hypothesis-generating and require validation in larger, longitudinal cohorts.

The FDA approved Moderna’s mFLUSIVA, the first mRNA influenza vaccine, for adults aged 50 and older. Availability is expected during the 2026–2027 respiratory virus season, with confirmatory evidence pending for adults 65 and older.

A 16-year-old girl presented with acute aphasia and right-sided weakness consistent with a large-vessel stroke syndrome. Neuroimaging confirmed left middle cerebral artery occlusion, but the underlying etiology was not immediately apparent.